COMPASS Pathways Free Cash Flow 2019-2025 | CMPS
COMPASS Pathways free cash flow from 2019 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| COMPASS Pathways Annual Free Cash Flow | |
|---|---|
| 2024 | -119.19 |
| 2023 | -97.44 |
| 2022 | -106.05 |
| 2021 | -68.08 |
| 2020 | -41.51 |
| 2019 | -17.98 |
| 2018 | -9.93 |
| COMPASS Pathways Quarterly Free Cash Flow | |
|---|---|
| 2025-06-30 | -84.35 |
| 2025-03-31 | -45.66 |
| 2024-12-31 | -119.19 |
| 2024-09-30 | -77.43 |
| 2024-06-30 | -55.24 |
| 2024-03-31 | -20.83 |
| 2023-12-31 | -97.44 |
| 2023-09-30 | -69.66 |
| 2023-06-30 | -52.58 |
| 2023-03-31 | -27.75 |
| 2022-12-31 | -106.05 |
| 2022-09-30 | -60.64 |
| 2022-06-30 | -41.62 |
| 2022-03-31 | -23.21 |
| 2021-12-31 | -68.08 |
| 2021-09-30 | -45.62 |
| 2021-06-30 | -31.64 |
| 2021-03-31 | -13.85 |
| 2020-12-31 | -41.51 |
| 2020-09-30 | -24.73 |
| 2020-03-31 | -4.50 |
| 2019-12-31 | |
| 2019-09-30 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.409B | $0.000B |
| COMPASS Pathways plc is a mental health care company. It operates principally in New York, USA. COMPASS Pathways plc is headquartered in London, UK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $149.662B | 27.76 |
| CVS Health (CVS) | United States | $88.998B | 11.07 |
| Elevance Health (ELV) | United States | $69.652B | 9.37 |
| Cencora (COR) | United States | $56.292B | 18.74 |
| DiDi Global (DIDIY) | China | $26.968B | 28.65 |
| Labcorp Holdings (LH) | United States | $22.478B | 17.87 |
| Natera (NTRA) | United States | $22.118B | 0.00 |
| BioMerieux (BMXMF) | France | $17.991B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.053B | 0.00 |
| ICON (ICLR) | Ireland | $14.420B | 13.87 |
| Medpace Holdings (MEDP) | United States | $13.005B | 34.42 |
| CochLear (CHEOY) | Australia | $12.576B | 0.00 |
| Viatris (VTRS) | United States | $12.393B | 4.41 |
| Solventum (SOLV) | United States | $12.269B | 12.66 |
| Revvity (RVTY) | United States | $10.411B | 18.34 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.110B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.247B | 0.00 |
| Avantor (AVTR) | United States | $8.699B | 12.76 |
| HealthEquity (HQY) | United States | $7.742B | 33.91 |
| Charles River Laboratories (CRL) | United States | $7.726B | 14.66 |
| Bausch + Lomb (BLCO) | Canada | $5.119B | 34.43 |
| Sotera Health (SHC) | United States | $4.488B | 25.08 |
| BrightSpring Health Services (BTSG) | United States | $4.090B | 31.20 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.617B | 82.83 |
| Alignment Healthcare (ALHC) | United States | $3.028B | 0.00 |
| Concentras Parent (CON) | United States | $2.931B | 18.59 |
| Surgery Partners (SGRY) | United States | $2.883B | 36.27 |
| Organon (OGN) | United States | $2.412B | 2.63 |
| Progyny (PGNY) | United States | $2.045B | 43.24 |
| Premier (PINC) | United States | $2.012B | 15.27 |
| Ardent Health (ARDT) | United States | $1.806B | 6.97 |
| GoodRx Holdings (GDRX) | United States | $1.779B | 30.12 |
| PACS (PACS) | United States | $1.739B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.393B | 9.30 |
| Teladoc Health (TDOC) | United States | $1.323B | 0.00 |
| Omada Health (OMDA) | $1.204B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.108B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.788B | 4.62 |
| AMN Healthcare Services Inc (AMN) | United States | $0.745B | 9.21 |
| CareDx (CDNA) | United States | $0.631B | 11.62 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| Nutex Health (NUTX) | United States | $0.525B | 7.95 |
| QDM (QDMI) | Hong Kong, SAR China | $0.525B | 90.00 |
| Agilon Health (AGL) | United States | $0.510B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.477B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.462B | 10.40 |
| SBC Medicals (SBC) | United States | $0.439B | 9.64 |
| Enhabit (EHAB) | United States | $0.404B | 26.57 |
| So-Young (SY) | China | $0.367B | 0.00 |
| Oncology Institute (TOI) | United States | $0.361B | 0.00 |
| LifeMD (LFMD) | United States | $0.309B | 0.00 |
| Beauty Health (SKIN) | United States | $0.278B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.218B | 0.00 |
| DocGo (DCGO) | United States | $0.164B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.137B | 0.00 |
| KindlyMD (NAKA) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.039B | 0.00 |
| ModivCare (MODV) | United States | $0.035B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.023B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |